Literature DB >> 21496551

Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.

Lawrence H C Kim1, Marcia Hogeling2, Orli Wargon2, Ashish Jiwane3, Susan Adams3.   

Abstract

Infantile hemangioma (IH) is the most common vascular tumor in early childhood. Ulceration is the most frequent complication, and its management can be challenging. We present 6 cases of ulcerated IH at a single pediatric center, which responded to oral propranolol within 2 to 6 weeks. We recommend that oral propranolol therapy be considered for the management of ulcerated IH as first-line treatment. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21496551     DOI： 10.1016/j.jpedsurg.2011.01.012

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN： 0022-3468            Impact factor:   2.545


  9 in total

1.  Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.

Authors:  Preeti Tiwari; Vaibhav Pandey; Ajay N Gangopadhyay; Shiv P Sharma; Dinesh K Gupta
Journal:  Oral Maxillofac Surg       Date:  2015-10-20

2.  Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells.

Authors:  Xiaorong Ma; Tinghui Zhao; Tianxiang Ouyang; Shujia Xin; Yueting Ma; Mengling Chang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Authors:  Brittany G Craiglow; Richard J Antaya
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

Review 4.  The changing face of complicated infantile hemangioma treatment.

Authors:  Deanna Menapace; Mario Mitkov; Richard Towbin; Marcia Hogeling
Journal:  Pediatr Radiol       Date:  2016-07-23

Review 5.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

6.  Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults.

Authors:  Arham Ali; David N Herndon; Ashish Mamachen; Samir Hasan; Clark R Andersen; Ro-Jon Grogans; Jordan L Brewer; Jong O Lee; Jamie Heffernan; Oscar E Suman; Celeste C Finnerty
Journal:  Crit Care       Date:  2015-05-04       Impact factor: 9.097

7.  Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas.

Authors:  Andrea Domenico Praticò; Filippo Caraci; Piero Pavone; Raffaele Falsaperla; Filippo Drago; Martino Ruggieri
Journal:  Drug Saf Case Rep       Date:  2015-12

Review 8.  Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy.

Authors:  Andreas Fette
Journal:  ScientificWorldJournal       Date:  2013-05-20

Review 9.  Infantile Hemangioma: A Brief Review.

Authors:  Madalina Bota; Gheorghe Popa; Cristina Blag; Alexandru Tataru
Journal:  Clujul Med       Date:  2015-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.